Mitochondrial dysfunction impairs human neuronal development and reduces neuronal network activity and synchronicity

Epilepsy, intellectual and cortical sensory deficits and psychiatric manifestations are among the most frequent manifestations of mitochondrial diseases. Yet, how mitochondrial dysfunction affects neural structure and function remains largely elusive. This is mostly due to the lack of a proper in vitro translational neuronal model system(s) with impaired energy metabolism. Leveraging the induced pluripotent stem cell technology, from a cohort of patients with the common pathogenic m.3243A>G variant of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), we differentiated excitatory cortical neurons (iNeurons) with normal (low heteroplasmy) and impaired (high heteroplasmy) mitochondrial function on an isogenic nuclear DNA background. iNeurons with high levels of heteroplasmy exhibited mitochondrial dysfunction, delayed neural maturation, reduced dendritic complexity and fewer functional excitatory synapses. Micro-electrode array recordings of neuronal networks with high heteroplasmy displayed reduced network activity and decreased synchronous network bursting. The impaired neural energy metabolism of iNeurons compromising the structural and functional integrity of neurons and neural networks, could be the primary driver of increased susceptibility to neuropsychiatric manifestations of mitochondrial disease.

[1]  D. Schubert,et al.  Distinct Pathogenic Genes Causing Intellectual Disability and Autism Exhibit a Common Neuronal Network Hyperactivity Phenotype. , 2020, Cell reports.

[2]  F. Gage,et al.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders. , 2019, Antioxidants & redox signaling.

[3]  E. Ruppin,et al.  Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility , 2019, Neuron.

[4]  D. Schubert,et al.  Neuronal network dysfunction in a human model for Kleefstra syndrome mediated by enhanced NMDAR signaling , 2019, bioRxiv.

[5]  R. Reinhart,et al.  Working memory revived in older adults by synchronizing rhythmic brain circuits , 2019, Nature Neuroscience.

[6]  D. Wallace Mitochondrial genetic medicine , 2018, Nature Genetics.

[7]  Lisanne M. Jenkins,et al.  Cognitive control and network disruption in remitted depression: a correlate of childhood adversity , 2018, Social cognitive and affective neuroscience.

[8]  T. Briston,et al.  Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention , 2018, Biochemical Society transactions.

[9]  J. Cobley Synapse Pruning: Mitochondrial ROS with Their Hands on the Shears , 2018, BioEssays : news and reviews in molecular, cellular and developmental biology.

[10]  A. Sawa,et al.  Dynamic Changes of the Mitochondria in Psychiatric Illnesses: New Mechanistic Insights From Human Neuronal Models , 2018, Biological Psychiatry.

[11]  A. Nierenberg,et al.  Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders , 2018, Biological Psychiatry.

[12]  G. Gallo,et al.  The role of mitochondria in axon development and regeneration , 2018, Developmental neurobiology.

[13]  M. Waxham,et al.  Morphology of mitochondria in spatially restricted axons revealed by cryo-electron tomography , 2018, bioRxiv.

[14]  E. Formisano,et al.  Anatomic & metabolic brain markers of the m.3243A>G mutation: A multi-parametric 7T MRI study , 2018, NeuroImage: Clinical.

[15]  Ping Liu,et al.  Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs , 2018, Protein & Cell.

[16]  É. Fino,et al.  Reconstituting Corticostriatal Network on-a-Chip Reveals the Contribution of the Presynaptic Compartment to Huntington's Disease. , 2018, Cell reports.

[17]  T. Asada,et al.  iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease. , 2017, Cell reports.

[18]  D. Wallace,et al.  Mitochondrial Etiology of Neuropsychiatric Disorders , 2017, Biological Psychiatry.

[19]  R. Mccullumsmith,et al.  Defects in Bioenergetic Coupling in Schizophrenia , 2017, Biological Psychiatry.

[20]  S. Nakagawa,et al.  Neural basis of major depressive disorder: Beyond monoamine hypothesis , 2017, Psychiatry and clinical neurosciences.

[21]  A. Andreazza,et al.  Bipolar Disorder as a Mitochondrial Disease , 2017, Biological Psychiatry.

[22]  F. Pallardó,et al.  Reversible Axonal Dystrophy by Calcium Modulation in Frataxin-Deficient Sensory Neurons of YG8R Mice , 2017, Front. Mol. Neurosci..

[23]  Kelsey S. Montgomery,et al.  Loss of Mitochondrial Ndufs4 in Striatal Medium Spiny Neurons Mediates Progressive Motor Impairment in a Mouse Model of Leigh Syndrome , 2017, Front. Mol. Neurosci..

[24]  Hila M. Ene,et al.  Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders? , 2017, Biological Psychiatry.

[25]  Andrew J. F. Valente,et al.  A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. , 2017, Acta histochemica.

[26]  H. Büeler,et al.  Loss of PINK1 leads to metabolic deficits in adult neural stem cells and impedes differentiation of newborn neurons in the mouse hippocampus , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  T. Uemura,et al.  Mitochondrial dysfunction induces dendritic loss via eIF2α phosphorylation , 2017, The Journal of cell biology.

[28]  Monica Frega,et al.  Rapid Neuronal Differentiation of Induced Pluripotent Stem Cells for Measuring Network Activity on Micro-electrode Arrays , 2017, Journal of visualized experiments : JoVE.

[29]  H. Roš,et al.  Loss of Dendritic Complexity Precedes Neurodegeneration in a Mouse Model with Disrupted Mitochondrial Distribution in Mature Dendrites , 2016, Cell reports.

[30]  V. Mootha,et al.  Natural underlying mtDNA heteroplasmy as a potential source of intra‐person hiPSC variability , 2016, The EMBO journal.

[31]  Fátima Sánchez-Cabo,et al.  Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing , 2016, Nature.

[32]  F. Polleux,et al.  LKB1 Regulates Mitochondria-Dependent Presynaptic Calcium Clearance and Neurotransmitter Release Properties at Excitatory Synapses along Cortical Axons , 2016, PLoS biology.

[33]  F. Gage,et al.  Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation , 2016, eLife.

[34]  C. Davies,et al.  Neuronal oscillations: A physiological correlate for targeting mitochondrial dysfunction in neurodegenerative diseases? , 2016, Neuropharmacology.

[35]  F. Scaglia,et al.  MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. , 2015, Molecular genetics and metabolism.

[36]  W. Kunz,et al.  Mitochondrial dysfunction and seizures: the neuronal energy crisis , 2015, The Lancet Neurology.

[37]  Mutsumi Yokota,et al.  Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming. , 2015, Human molecular genetics.

[38]  N. Lax,et al.  Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease , 2015, Neuropathology and applied neurobiology.

[39]  Pierre J. Magistretti,et al.  A Cellular Perspective on Brain Energy Metabolism and Functional Imaging , 2015, Neuron.

[40]  Chikaaki Motoda,et al.  Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels , 2015, FEBS open bio.

[41]  G. Alves,et al.  Structural neuroimaging findings in major depressive disorder throughout aging: a critical systematic review of prospective studies. , 2015, CNS & neurological disorders drug targets.

[42]  A. Prigione Induced pluripotent stem cells (iPSCs) for modeling mitochondrial DNA disorders. , 2015, Methods in molecular biology.

[43]  Vincent Procaccio,et al.  Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming , 2014, Proceedings of the National Academy of Sciences.

[44]  P. Hof,et al.  Metabolic costs and evolutionary implications of human brain development , 2014, Proceedings of the National Academy of Sciences.

[45]  R. Swerdlow,et al.  Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies , 2014, Redox biology.

[46]  E. Wanker,et al.  HIF1α Modulates Cell Fate Reprogramming Through Early Glycolytic Shift and Upregulation of PDK1–3 and PKM2 , 2014, Stem cells.

[47]  J. Twiss,et al.  Mitochondria coordinate sites of axon branching through localized intra-axonal protein synthesis. , 2013, Cell reports.

[48]  J. Adjaye,et al.  Mitochondrial Function in Pluripotent Stem Cells and Cellular Reprogramming , 2013, Gerontology.

[49]  N. Logothetis,et al.  Scaling Brain Size, Keeping Timing: Evolutionary Preservation of Brain Rhythms , 2013, Neuron.

[50]  A. Suomalainen,et al.  Tissue- and cell-type–specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model , 2013, Proceedings of the National Academy of Sciences.

[51]  Kazuki Obashi,et al.  Regulation of mitochondrial dynamics and distribution by synapse position and neuronal activity in the axon , 2013, The European journal of neuroscience.

[52]  T. Südhof,et al.  Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells , 2013, Neuron.

[53]  S. Leistedt,et al.  Brain, networks, depression, and more , 2013, European Neuropsychopharmacology.

[54]  S. Dimauro,et al.  Human mitochondrial DNA: roles of inherited and somatic mutations , 2012, Nature Reviews Genetics.

[55]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[56]  G. Serafini,et al.  Neuroplasticity and major depression, the role of modern antidepressant drugs. , 2012, World journal of psychiatry.

[57]  K. Nakao,et al.  Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation , 2012, Diabetologia.

[58]  A. Suomalainen,et al.  Mechanisms of mitochondrial diseases , 2012, Annals of medicine.

[59]  P. Dan,et al.  The interplay between SUCLA2, SUCLG2, and mitochondrial DNA depletion. , 2011, Biochimica et biophysica acta.

[60]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[61]  Markus Schuelke,et al.  Gamma oscillations in the hippocampus require high complex I gene expression and strong functional performance of mitochondria. , 2011, Brain : a journal of neurology.

[62]  J. Adjaye,et al.  Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. , 2010, The International journal of developmental biology.

[63]  Sergio Martinoia,et al.  Investigating neuronal activity by SPYCODE multi-channel data analyzer , 2010, Neural Networks.

[64]  Xiao-Jing Wang Neurophysiological and computational principles of cortical rhythms in cognition. , 2010, Physiological reviews.

[65]  R. Palmiter,et al.  Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome , 2010, Proceedings of the National Academy of Sciences.

[66]  R. Rodenburg Biochemical diagnosis of mitochondrial disorders , 2010, Journal of Inherited Metabolic Disease.

[67]  Lily Yeh Jan,et al.  Branching out: mechanisms of dendritic arborization , 2010, Nature Reviews Neuroscience.

[68]  J. Houštěk,et al.  Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid , 2010, Neurochemistry International.

[69]  N. Lax,et al.  The mitochondrial brain: From mitochondrial genome to neurodegeneration , 2010, Biochimica et biophysica acta.

[70]  J. Finsterer Mitochondrial disorders, cognitive impairment and dementia , 2009, Journal of the Neurological Sciences.

[71]  C. Elger,et al.  Mitochondrial involvement in temporal lobe epilepsy , 2009, Experimental Neurology.

[72]  David S. Park,et al.  Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission* , 2009, Journal of Biological Chemistry.

[73]  S. Wortmann,et al.  Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. , 2009, Journal of affective disorders.

[74]  E. Shoubridge,et al.  The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2. , 2008, Human molecular genetics.

[75]  Hoon-Chul Kang,et al.  Mitochondrial respiratory chain defects: Underlying etiology in various epileptic conditions , 2008, Epilepsia.

[76]  N. Spruston Pyramidal neurons: dendritic structure and synaptic integration , 2008, Nature Reviews Neuroscience.

[77]  P. Mitchell,et al.  Population prevalence of the MELAS A3243G mutation. , 2007, Mitochondrion.

[78]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[79]  D. Turnbull,et al.  Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement , 2006, Neuropathology and applied neurobiology.

[80]  Jakub Otáhal,et al.  Metabolic dysfunction during neuronal activation in the ex vivo hippocampus from chronic epileptic rats and humans. , 2005, Brain : a journal of neurology.

[81]  W. Hauser,et al.  Comment on Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) , 2005, Epilepsia.

[82]  Yasunori Hayashi,et al.  The Importance of Dendritic Mitochondria in the Morphogenesis and Plasticity of Spines and Synapses , 2004, Cell.

[83]  I. Meinertzhagen,et al.  Axonal Transport of Mitochondria to Synapses Depends on Milton, a Novel Drosophila Protein , 2002, Neuron.

[84]  D. Turnbull,et al.  The epidemiology of pathogenic mitochondrial DNA mutations , 2000, Annals of neurology.

[85]  K. Majamaa,et al.  Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. , 1998, American journal of human genetics.

[86]  S. Pavlakis,et al.  Topical Review: Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike Episodes (MELAS): Current Concepts , 1994, Journal of child neurology.

[87]  Samuel Thayer,et al.  Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[88]  P. Hollenbeck,et al.  The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. , 1993, Journal of cell science.

[89]  S. Dimauro,et al.  MELAS: Clinical features, biochemistry, and molecular genetics , 1992, Annals of neurology.

[90]  K. Nihei,et al.  Respiration-deficient Cells AreCausedbya Single Point Mutation intheMitochondrial tRNA-Leu(UUR)Genein Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, andStrokelike Episodes (MELAS) , 1991 .

[91]  K. Nihei,et al.  A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). , 1990, Biochemical and biophysical research communications.

[92]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.

[93]  Agatha Lenartowicz,et al.  Aberrant Modulation of Brain Oscillatory Activity and Attentional Impairment in Attention-Deficit/Hyperactivity Disorder. , 2018, Biological psychiatry. Cognitive neuroscience and neuroimaging.

[94]  I. Soltesz,et al.  Organization and control of epileptic circuits in temporal lobe epilepsy. , 2016, Progress in brain research.

[95]  S. Dimauro,et al.  Mitochondrial diseases , 2016, Nature Reviews Disease Primers.

[96]  V. Weissig,et al.  Mitochondrial Medicine , 2015, Methods in Molecular Biology.

[97]  W. Kunz,et al.  Mitochondrial dysfunction in epilepsy. , 2012, Mitochondrion.

[98]  L. Van Aelst,et al.  Characterization of oligophrenin-1, a RhoGAP lost in patients affected with mental retardation: lentiviral injection in organotypic brain slice cultures. , 2008, Methods in enzymology.

[99]  P. Srere,et al.  [1] Citrate synthase. [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)] , 1969 .